Page 27 - Endoscopy News Today

Steroid use may increase relapse risk in patients who have histologically active ulcerative colitis with a Mayo endoscopic subcore of 1.

The more antibiotics prescribed to patients 60 and older, the more likely they were to develop inflammatory bowel disease, suggesting antibiotic use could explain some of the growth in Crohn's disease and ulcerative colitis in older people, according to a review of 2.3 million patient records in a study selected for presentation at Digestive Disease Week 2022.

Patients with pancreatic ductal adenocarcinoma (PDAC) were six times more likely to have had gallstone disease within the year prior to diagnosis than non-cancer patients, suggesting gallstones could be a warning sign for this aggressive and deadly cancer, according to research to be presented at Digestive Disease Week (DDW) 2022.

Colonoscopies performed with computer-aided detection, or artificial intelligence, (AI) saw an increase in the overall rate of detection of adenoma, or cancerous and precancerous polyps, by 27 percent in average-risk patients, according to new data presented today at the Digestive Disease Week Annual Meeting.

WEDNESDAY, May 25, 2022 (HealthDay News) -- If you use pot, you may need more sedation than normal during a gastric endoscopy, according to a new study.

A biomarker panel used on tissue samples obtained via a swallowable capsule can detect esophageal squamous cell cancer (ESCC) and may be particularly useful where endoscopy is not widely available.

Five-year survival for younger adults with colorectal cancer (CRC) improved only for Whites between 1992 and 2013, according to a new analysis to be presented at Digestive Disease Week 2022.

Patients who use cannabis required higher levels of sedation during gastric endoscopies than non-users, according to research to be presented at Digestive Disease Week 2022.

Liver transplants from drug overdose donors rose significantly in the pandemic's first year, helping keep the number of liver transplants in the U.S. stable despite COVID-19 disruptions, according to a study to be presented at Digestive Disease Week 2022.

The prevalence of esophageal cancer and Baretts esophagus has increased substantially among middle-aged adults during the past 5 years, warn the authors of a new study from Florida.